'We're Confident Arrowhead's ARC-520 Is Active Drug For HBV,' Piper Jaffray Says

By: via Benzinga
Shares of Arrowhead Research Corp (NASDAQ: ARWR) lost more than 50 percent from a year ago. Edward Tenthoff of Piper Jaffray left ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.